Jung Seungyoun, Allen Naomi, Arslan Alan A, Baglietto Laura, Brinton Louise A, Egleston Brian L, Falk Roni, Fortner Renée T, Helzlsouer Kathy J, Idahl Annika, Kaaks Rudolph, Lundin Eva, Merritt Melissa, Onland-Moret Charlotte, Rinaldi Sabina, Sánchez María-José, Sieri Sabina, Schock Helena, Shu Xiao-Ou, Sluss Patrick M, Staats Paul N, Travis Ruth C, Tjønneland Anne, Trichopoulou Antonia, Tworoger Shelley, Visvanathan Kala, Krogh Vittorio, Weiderpass Elisabete, Zeleniuch-Jacquotte Anne, Zheng Wei, Dorgan Joanne F
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Fertil Steril. 2017 Apr;107(4):1012-1022.e2. doi: 10.1016/j.fertnstert.2017.02.105.
To identify reproductive, lifestyle, hormonal, and other correlates of circulating antimüllerian hormone (AMH) concentrations in mostly late premenopausal women.
Cross-sectional study.
Not applicable.
PATIENT(S): A total of 671 premenopausal women not known to have cancer.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Concentrations of AMH were measured in a single laboratory using the picoAMH ELISA. Multivariable-adjusted median (and interquartile range) AMH concentrations were calculated using quantile regression for several potential correlates.
RESULT(S): Older women had significantly lower AMH concentrations (≥40 [n = 444] vs. <35 years [n = 64], multivariable-adjusted median 0.73 ng/mL vs. 2.52 ng/mL). Concentrations of AMH were also significantly lower among women with earlier age at menarche (<12 [n = 96] vs. ≥14 years [n = 200]: 0.90 ng/mL vs. 1.12 ng/mL) and among current users of oral contraceptives (n = 27) compared with never or former users (n = 468) (0.36 ng/mL vs. 1.15 ng/mL). Race, body mass index, education, height, smoking status, parity, and menstrual cycle phase were not significantly associated with AMH concentrations. There were no significant associations between AMH concentrations and androgen or sex hormone-binding globulin concentrations or with factors related to blood collection (e.g., sample type, time, season, and year of blood collection).
CONCLUSION(S): Among premenopausal women, lower AMH concentrations are associated with older age, a younger age at menarche, and currently using oral contraceptives, suggesting these factors are related to a lower number or decreased secretory activity of ovarian follicles.
确定大多数接近绝经的女性循环抗苗勒管激素(AMH)浓度与生殖、生活方式、激素及其他相关因素之间的关系。
横断面研究。
不适用。
总共671名未患癌症的绝经前女性。
无。
在单一实验室使用picoAMH ELISA法测量AMH浓度。使用分位数回归计算几种潜在相关因素的多变量调整中位数(及四分位数间距)AMH浓度。
年龄较大的女性AMH浓度显著较低(≥40岁[n = 444]与<35岁[n = 64]相比,多变量调整中位数为0.73 ng/mL与2.52 ng/mL)。初潮年龄较早的女性(<12岁[n = 96]与≥14岁[n = 200]相比:0.90 ng/mL与1.12 ng/mL)以及目前口服避孕药使用者(n = 27)与从未使用或曾经使用过避孕药者(n = 468)相比,AMH浓度也显著较低(0.36 ng/mL与1.15 ng/mL)。种族、体重指数、教育程度、身高、吸烟状况、生育次数和月经周期阶段与AMH浓度无显著关联。AMH浓度与雄激素或性激素结合球蛋白浓度以及与采血相关因素(如样本类型、时间、季节和采血年份)之间无显著关联。
在绝经前女性中,较低的AMH浓度与年龄较大、初潮年龄较小以及目前使用口服避孕药有关,提示这些因素与卵巢卵泡数量减少或分泌活性降低有关。